W538

granules et solution en gouttes en gouttes buvable en gouttes · orale / sublinguale

Directory source checks passedOriginal source language: French

Source data retrieved: 2026-09-17. Clinical review is not yet available.

Formgranules et solution en gouttes en gouttes buvable en gouttes

Routeorale / sublinguale

Ingredient entries4

CountryFrance

Product identity

At a glance

Authorisation holder: WELEDA
Authorisation status: Autorisation active
Market status: Commercialisée
Country: France
Source reference: CIS 69689672

Reported market status does not confirm current pharmacy stock.

From the official composition record

Ingredients & strength

Source entries are shown individually. An active substance (SA) and its reference moiety (FT) may describe the same ingredient; do not add their strengths together.

Source composition entries for W538
Ingredient	Strength / reference	Source role
PHOSPHORUS POUR PRÉPARATIONS HOMÉOPATHIQUESgranules	8DHune dose de 0,5 ml	SAGroup 14
SAMBUCUS NIGRA POUR PRÉPARATIONS HOMÉOPATHIQUESgranules	4DHune dose de 0,5 ml	SAGroup 22
BERBERIS VULGARIS FRUCTUS POUR PRÉPARATIONS HOMÉOPATHIQUESgranules	6DHune dose de 0,5 ml	SAGroup 13
TEUCRIUM SCORODONIA POUR PRÉPARATIONS HOMÉOPATHIQUESgranules	5DHune dose de 0,5 ml	SAGroup 24
PHOSPHORUS POUR PRÉPARATIONS HOMÉOPATHIQUESsolution buvable en gouttes	8DHune dose de 0,5 ml	SAGroup 20
SAMBUCUS NIGRA POUR PRÉPARATIONS HOMÉOPATHIQUESsolution buvable en gouttes	4DHune dose de 0,5 ml	SAGroup 21
BERBERIS VULGARIS FRUCTUS POUR PRÉPARATIONS HOMÉOPATHIQUESsolution buvable en gouttes	6DHune dose de 0,5 ml	SAGroup 16
TEUCRIUM SCORODONIA POUR PRÉPARATIONS HOMÉOPATHIQUESsolution buvable en gouttes	5DHune dose de 0,5 ml	SAGroup 23

Pack references

Presentations (2)

1 tube(s) de 4 g

CIP13 3400930226216

Présentation active · Déclaration de commercialisation

1 flacon(s) de 60 ml

CIP13 3400930226230

Présentation active · Déclaration de commercialisation

From the French medicines authority

Official documents

The official product entry provides access to the patient leaflet and professional product information when available. Documents are in French and availability varies by medicine.

Open the official product entryBDPM · CIS 69689672 · Opens in a new tab

Check the medicine name, strength and form against your pack. The authority’s current documents may be newer than the catalogue snapshot shown here.

Where this information comes from

Sources & dates

Base de données publique des médicaments (BDPM), France. Retrieval dates record when we obtained the source files; they are not clinical review dates or a guarantee of current stock.

Source files and their retrieval dates
Source file	Retrieved	Source file modified
fr_products.txt	2026-09-17	Not supplied
fr_composition.txt	2026-09-17	Not supplied
fr_packs.txt	2026-09-17	Not supplied

Directory source checks cover the factual catalogue record.Molindra clinical guidance has not yet been reviewed or published for this medicine.

Our sources and review process →